academic article

• Cost-Effectiveness of Nivolumab-Ipilimumab Combination Therapy Compared with Monotherapy for First-Line Treatment of Metastatic Melanoma in the United States..  Journal of managed care & specialty pharmacy.  23:653-664. 2017